Vanderbilt Ingram Cancer Center Archives
May. 16, 2019—Mariana Byndloss, DVM, PhD, has been selected to participate in the Future Research Leaders Conference at the National Institutes of Health.
May. 3, 2019—Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema.
May. 3, 2019—Malignant rhabdoid tumor (MRT) is one of the most aggressive and lethal childhood cancers. Although rare — about 20 to 25 new cases are diagnosed annually in the United States — there is no standard effective treatment for the disease, which is driven by loss of an anti-cancer protein called SNF5. The chances are very small that a child will survive a year after MRT diagnosis.
Apr. 25, 2019—Tony Hunter, PhD, an internationally recognized leader in the study of cell growth control, will deliver the final spring Flexner Discovery Lecture on Thursday, May 2.
Apr. 22, 2019—The varying roles that signaling molecules play in progression of cancer is the focus of the Vanderbilt-Ingram Cancer Center 20th Annual Scientific Retreat when some of the nation’s top experts will speak about “Signal Transduction in Cancer Initiation, Progression and Treatment.”
Apr. 11, 2019—When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.
Mar. 28, 2019—The Terry Burke Fund for Bladder Cancer Research at Vanderbilt-Ingram Cancer Center is supporting a range of discovery research aimed at improving outcomes for bladder cancer patients, and it is helping train the next generation of bladder cancer physician-scientists.
Mar. 14, 2019—Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.
Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
Feb. 28, 2019—Some cancer patients receiving CAR-T infusions can now avoid hospital stays because of a telemedicine program launched by Vanderbilt-Ingram Cancer Center.